This report provides comprehensive information on the current therapeutic developmental pipeline of Braasch Biotech LLCs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Scope The report provides brief overview of Braasch Biotech LLC including business description, key information and facts, and its locations and subsidiaries The report reviews current pipeline of Braasch Biotech LLCs human therapeutic division and enlists all their major and minor projects The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones Special feature on out-licensed and partnered product portfolio The report summarizes all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Braasch Biotech LLCs pipeline products Reasons to buy Evaluate Braasch Biotech LLCs strategic position with total access to detailed information on its product pipeline Assess the growth potential of Braasch Biotech LLC in its therapy areas of focus Identify new drug targets and therapeutic classes in the Braasch Biotech LLCs R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps Develop strategic initiatives by understanding the focus areas of Braasch Biotech LLC and exploit collaboration and partnership opportunities

1. Braasch Biotech LLC - Product Pipeline Review - 2015
Global Markets Directs, Braasch Biotech LLC Product Pipeline Review 2015, provides an overview of the Braasch Biotech LLCs pharmaceutical research and
development focus.
This report provides comprehensive information on the current therapeutic developmental pipeline of Braasch Biotech LLCs, complete with comparative
analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews
latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built
using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and
featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug
profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the
latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that
the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by
identifying new targets and MOAs to produce first-in-class and best-in-class products.
Scope
The report provides brief overview of Braasch Biotech LLC including business description, key information and facts, and its locations and subsidiaries The
report reviews current pipeline of Braasch Biotech LLCs human therapeutic division and enlists all their major and minor projects The report features product
description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones Special feature
on out-licensed and partnered product portfolio The report summarizes all the dormant and discontinued pipeline projects Latest company statement Latest news
and deals relating to the Braasch Biotech LLCs pipeline products
Reasons to buy
Evaluate Braasch Biotech LLCs strategic position with total access to detailed information on its product pipeline Assess the growth potential of Braasch
Biotech LLC in its therapy areas of focus Identify new drug targets and therapeutic classes in the Braasch Biotech LLCs R&D portfolio and develop key strategic
initiatives to reinforce pipeline in those areas Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps Develop strategic
initiatives by understanding the focus areas of Braasch Biotech LLC and exploit collaboration and partnership opportunities Identify emerging players with
potentially strong product portfolio and create effective counter-strategies to gain competitive advantage Plan mergers and acquisitions effectively by identifying
the most promising pipeline of Braasch Biotech LLC Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the
most attractive projects to enhance and expand business potential and scope Explore the dormant and discontinued projects of Braasch Biotech LLC and identify
potential opportunities in those areas Avoid Intellectual Property Rights related issues
table Of Contents
table Of Contents 2
list Of Tables 3
list Of Figures 3
braasch Biotech Llc Snapshot 4
braasch Biotech Llc Overview 4
key Information 4
key Facts 4
braasch Biotech Llc - Research And Development Overview 5
key Therapeutic Areas 5
braasch Biotech Llc - Pipeline Review 7
pipeline Products By Stage Of Development 7
pipeline Products - Monotherapy 8
braasch Biotech Llc - Pipeline Products Glance 9
braasch Biotech Llc - Early Stage Pipeline Products 9
preclinical Products/combination Treatment Modalities 9
braasch Biotech Llc - Drug Profiles 10
jh-17 10
product Description 10
mechanism Of Action 10
r&d Progress 10
jh-18 11
product Description 11
mechanism Of Action 11
r&d Progress 11
vaccine For Growth Hormone Deficiencies 12
product Description 12
mechanism Of Action 12
r&d Progress 12
vaccine For Type 2 Diabetes 13
product Description 13
mechanism Of Action 13
r&d Progress 13
Braasch Biotech LLC - Product Pipeline Review - 2015

2. braasch Biotech Llc - Pipeline Analysis 14
braasch Biotech Llc - Pipeline Products By Target 14
braasch Biotech Llc - Pipeline Products By Molecule Type 15
braasch Biotech Llc - Recent Pipeline Updates 16
braasch Biotech Llc - Locations And Subsidiaries 17
head Office 17
appendix 18
methodology 18
coverage 18
secondary Research 18
primary Research 18
expert Panel Validation 18
contact Us 18
disclaimer 19
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your
research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and
across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an
informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Contact:
Sales Team,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
Braasch Biotech LLC - Product Pipeline Review - 2015